ACCOST-HH: Adrecizumab in cardiogenic shock

27 August 2021 (10:52 - 11:03)
Organised by:
Congress Presentation Part of: Late Breaking Trials in ACS Cardiogenic Shock ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by